Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

NIH offers synthetic HIV protease gene for design of HIV-1 protease inhibitors

Oct. 25, 1996

Synthetic HIV-1 and HIV-2 proteases from NIH available for licensing

Oct. 25, 1996

AM-1401 available for licensing

Oct. 25, 1996

Expanded access program allowed for Remune

Oct. 25, 1996

Nucleotide analogue enters clinical trials for HIV

Oct. 25, 1996

Water-soluble prodrug of HIV protease inhibitor reported by DuPont Merck

Oct. 25, 1996

Torii prepares agents for HIV infection

Oct. 25, 1996

Buckminsterfullerene inventors receive Nobel Prize in Chemistry

Oct. 18, 1996

South and Central American development and distribution agreement for Remune

Oct. 18, 1996

Pivotal trial of thalidomide in AIDS patients completed

Oct. 18, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 28, 2025
New drugs with the same old resistance tricks?
BioWorld
According to the World Health Organization (WHO), multidrug-resistant pathogens caused over 1.27 million deaths worldwide in 2020. And figures are rising, with...
OS Therapies heading to FDA with positive osteosarcoma data
BioWorld
With positive data in hand from its phase IIb trial testing immunotherapy candidate OST-HER2 in osteosarcoma, OS Therapies Inc. anticipates a regulatory filing...
Vilastobart set apart? Xilio phase II combo performs in CRC
BioWorld
“The [colorectal cancer field is moving, and thankfully it’s moving quickly,” said Marwan Fakih, gastrointestinal specialist at City of Hope, speaking about...